Skip to main content
Log in

A significant imbalance in mitosis versus apoptosis accelerates the growth rate of sessile serrated adenoma/polyps

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Sessile serrated adenoma/polyps (SSA/Ps) of the colon are thought to be precursors of sporadic carcinomas. Although it is suggested that SSA/P may grow rapidly from the early stage, its cell kinetics remains obscure. To solve this problem, we analyzed the mitotic and apoptotic activity of normal crypts, microvesicular hyperplastic polyps (MVHPs), and tubular adenomas (TAs), using phospho-histone H3 and cleaved caspase 3 immunohistochemistry. The mitotic index for SSA/Ps (mean, 5.63) and TAs (6.98) was significantly higher than those for normal crypts (2.72) and MVHPs (2.86). Of all tested lesions, the apoptotic index was lowest for SSA/Ps (0.96; normal, 2.71; MVHPs, 2.62; TAs, 6.01) with statistically significant differences. The net growth ratio was close to 1.0 in normal crypts (1.07) while remaining low in MVHPs (1.06) and TAs (1.38), but was markedly elevated in SSA/Ps (7.32, P < 0.01) due to the large imbalance between mitosis and apoptosis. As to apoptosis regulatory proteins, expression of anti-apoptotic Bcl-2 was significantly reduced or undetectable in MVHPs and SSA/Ps, while TAs showed stronger staining than normal crypts. Expression of pro-apoptotic Bax and its activators, Bim and Bad, was significantly reduced in MVHPs and SSA/Ps. We suggest that other complex mechanisms may act synergistically with Bax, Bim, or Bad deficiency to regulate apoptosis suppression in SSA/Ps.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Noffsinger AE (2009) Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 4:343–364

    Article  PubMed  CAS  Google Scholar 

  2. Snover DC, Ahnen DJ, Burt RW, Odze RD (2010) Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system, 4th edn. IARC, Lyon, pp 160–165

    Google Scholar 

  3. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, Pike T, Simms LA, Young J, James M, Montgomery GW, Appleyard M, Hewett D, Togashi K, Jass JR, Leggett BA (2006) High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131:1400–1407

    Article  PubMed  CAS  Google Scholar 

  4. Groff RJ, Nash R, Ahnen DJ (2008) Significance of serrated polyps of the colon. Curr Gastroenterol Rep 10:490–498

    Article  PubMed  Google Scholar 

  5. Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, Snover DC (2008) Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 32:21–29

    Article  PubMed  Google Scholar 

  6. Goldstein NS, Bhanot P, Odish E, Hunter S (2003) Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 119:778–796

    Article  PubMed  Google Scholar 

  7. Oono Y, Fu K, Nakamura H, Iriguchi Y, Yamamura A, Tomino Y, Oda J, Mizutani M, Takayanagi S, Kishi D, Shinohara T, Yamada K, Matumoto J, Imamura K (2009) Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 54:906–909

    Article  PubMed  Google Scholar 

  8. Lash RH, Genta RM, Schuler CM (2010) Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 63:681–686

    Article  PubMed  Google Scholar 

  9. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311–322

    Article  PubMed  CAS  Google Scholar 

  10. Shanmugathasan M, Jothy S (2000) Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 50:273–279

    Article  PubMed  CAS  Google Scholar 

  11. Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN (2004) The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol 28:1532–1536

    Article  PubMed  Google Scholar 

  12. Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D, Glatz K (2006) Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol 30:83–89

    Article  PubMed  Google Scholar 

  13. Jin Z, El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4:139–163

    Article  PubMed  CAS  Google Scholar 

  14. Duan WR, Garner DS, Williams SD, Funckes-Shippy CL, Spath IS, Blomme EA (2003) Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199:221–228

    Article  PubMed  CAS  Google Scholar 

  15. Gown AM, Willingham MC (2002) Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 50:449–454

    Article  PubMed  CAS  Google Scholar 

  16. Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47–59

    Article  PubMed  CAS  Google Scholar 

  17. Horkko TT, Makinen MJ (2003) Colorectal proliferation and apoptosis in serrated versus conventional adenoma-carcinoma pathway: growth, progression and survival. Scand J Gastroenterol 38:1241–1248

    Article  PubMed  CAS  Google Scholar 

  18. Tateyama H, Li W, Takahashi E, Miura Y, Sugiura H, Eimoto T (2002) Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition of apoptosis. Am J Surg Pathol 26:249–256

    Article  PubMed  Google Scholar 

  19. Dahl J, Greenson JK (2007) Colon. In: Mills SE (ed) Histopathology for pathologists, 3rd edn. LWW, Philadelphia, pp 627–648

    Google Scholar 

  20. Strater J, Koretz K, Gunthert AR, Moller P (1995) In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut 37:819–825

    Article  PubMed  CAS  Google Scholar 

  21. Jass JR (2001) Serrated route to colorectal cancer: back street or super highway? J Pathol 193:283–285

    Article  PubMed  CAS  Google Scholar 

  22. Hoff G, Foerster A, Vatn MH, Sauar J, Larsen S (1986) Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. Scand J Gastroenterol 21:853–862

    Article  PubMed  CAS  Google Scholar 

  23. Hofstad B, Vatn MH, Andersen SN, Huitfeldt HS, Rognum T, Larsen S, Osnes M (1996) Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut 39:449–456

    Article  PubMed  CAS  Google Scholar 

  24. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L (2007) Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 132:96–102

    Article  PubMed  Google Scholar 

  25. Bressler B, Paszat LF, Vinden C, Li C, He J, Rabeneck L (2004) Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology 127:452–456

    Article  PubMed  Google Scholar 

  26. Snover DC (2011) Update on the serrated pathway to colorectal carcinoma. Hum Pathol 42:1–102

    Article  PubMed  Google Scholar 

  27. Fujita K, Yamamoto H, Matsumoto T, Hirahashi M, Gushima M, Kishimoto J, Nishiyama K, Taguchi T, Yao T, Oda Y (2011) Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol 35:295–304

    Article  PubMed  Google Scholar 

  28. Higuchi T, Sugihara K, Jass JR (2005) Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 47:32–40

    Article  PubMed  CAS  Google Scholar 

  29. Higuchi T, Jass JR (2004) My approach to serrated polyps of the colorectum. J Clin Pathol 57:682–686

    Article  PubMed  CAS  Google Scholar 

  30. Komori K, Ajioka Y, Watanabe H, Oda K, Nimura Y (2003) Proliferation kinetics and apoptosis of serrated adenoma of the colorectum. Pathol Int 53:277–283

    Article  PubMed  Google Scholar 

  31. Ladas SD, Kitsanta P, Triantafyllou K, Tzathas C, Spiliadi C, Raptis SA (2005) Cell turnover of serrated adenomas. J Pathol 206:62–67

    Article  PubMed  CAS  Google Scholar 

  32. Mitomi H, Sada M, Kobayashi K, Igarashi M, Mori A, Kanazawa H, Nishiyama Y, Ihara A, Otani Y (2003) Different apoptotic activity and p21(WAF1/CIP1), but not p27(Kip1), expression in serrated adenomas as compared with traditional adenomas and hyperplastic polyps of the colorectum. J Cancer Res Clin Oncol 129:449–455

    Article  PubMed  CAS  Google Scholar 

  33. Zinkel S, Gross A, Yang E (2006) BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13:1351–1359

    Article  PubMed  CAS  Google Scholar 

  34. Shamas-Din A, Brahmbhatt H, Leber B, Andrews DW (2011) BH3-only proteins: orchestrators of apoptosis. Biochim Biophys Acta 1813:508–520

    Article  PubMed  CAS  Google Scholar 

  35. Coultas L, Bouillet P, Stanley EG, Brodnicki TC, Adams JM, Strasser A (2004) Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol Cell Biol 24:1570–1581

    Article  PubMed  CAS  Google Scholar 

  36. Hubner A, Cavanagh-Kyros J, Rincon M, Flavell RA, Davis RJ (2010) Functional cooperation of the proapoptotic Bcl2 family proteins Bmf and Bim in vivo. Mol Cell Biol 30:98–105

    Article  PubMed  CAS  Google Scholar 

  37. Goldstein NS (2006) Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol 125:146–153

    PubMed  CAS  Google Scholar 

  38. Liu S, Bishop WR, Liu M (2003) Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 6:183–195

    Article  PubMed  CAS  Google Scholar 

  39. Minoo P, Moyer MP, Jass JR (2007) Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol 212:124–133

    Article  PubMed  CAS  Google Scholar 

  40. Mebratu Y, Tesfaigzi Y (2009) How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle 8:1168–1175

    Article  PubMed  CAS  Google Scholar 

  41. Ewings KE, Wiggins CM, Cook SJ (2007) Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle 6:2236–2240

    Article  PubMed  CAS  Google Scholar 

  42. Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, Ruszkiewicz AR, Barker M, Buchanan D, Young J, Jass JR (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55:1467–1474

    Article  PubMed  CAS  Google Scholar 

  43. O’Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30:1491–1501

    Article  PubMed  Google Scholar 

  44. Dong SM, Lee EJ, Jeon ES, Park CK, Kim KM (2005) Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol 18:170–178

    Article  PubMed  CAS  Google Scholar 

  45. McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD, Barker MA, Arnold S, Simms LA, Leggett BA, Young J, Jass JR (2004) Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 3:101–107

    Article  PubMed  CAS  Google Scholar 

  46. Hassen S, Ali N, Chowdhury P (2012) Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer. World J Gastrointest Pathophysiol 3:71–79

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hirotaka Koizumi.

Additional information

Akira Endo and Hirotaka Koizumi contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Endo, A., Koizumi, H., Takahashi, M. et al. A significant imbalance in mitosis versus apoptosis accelerates the growth rate of sessile serrated adenoma/polyps. Virchows Arch 462, 131–139 (2013). https://doi.org/10.1007/s00428-012-1365-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-012-1365-1

Keywords

Navigation